Microencapsulated subunit vaccine approach to enterotoxigenic Escherichia coli and other mucosal pathogens

Advanced Drug Delivery Reviews

Volumn 57, Issue 9, 2005, Pages 1362-1380

  Byrd, Wyatt ^a   De Lorimier, Arthur ^b   Zheng, Zi Rong ^a   Cassels, Frederick J ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Biodegradable microspheres; ETEC; Mucosal pathogens; Subunit vaccines

Indexed keywords

BACTERIOPHAGES; CELLS; ENCAPSULATION; ESCHERICHIA COLI; IMMUNOLOGY; MEDICAL PROBLEMS; PATHOLOGY;

COLONIZATION; MICROENCAPSULATION; MORBIDITY; MUCOSAL PATHOGENS; RESPIRATORY TRACTS;

VACCINES;

ANTHRAX VACCINE; CHOLERA VACCINE; DIPHTHERIA VACCINE; ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES VACCINE; MENINGITIS VACCINE; MICROSPHERE; MUMPS VACCINE; PERTUSSIS VACCINE; PLAGUE VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; POLY(ORTHO ESTER); POLYGLYCOLIC ACID; POLYMER; RABIES VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE; TETANUS TOXOID; TYPHOID VACCINE; VARICELLA ZOSTER VACCINE; VIRUS VACCINE; YELLOW FEVER VACCINE;

BACTERIAL IMMUNITY; BORDETELLA PERTUSSIS; BRUCELLOSIS; CORYNEBACTERIUM DIPHTHERIAE; DISEASE CONTROL; DRUG DELIVERY SYSTEM; ENCAPSULATION; ESCHERICHIA COLI; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNE RESPONSE; INFLUENZA VIRUS; MICROENCAPSULATION; MORBIDITY; MORTALITY; MUCOSAL IMMUNITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS;

ADHESINS, ESCHERICHIA COLI; ANIMALS; DRUG COMPOUNDING; ESCHERICHIA COLI; HUMANS; INTESTINAL MUCOSA; MICROSPHERES; VIRAL VACCINES;

EID: 20344385757     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2005.01.014     Document Type: Review

References (159)

1. S.N. Abraham, N. Sharon, and I. Ofek Adhesion of bacteria to mucosal surfaces P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.P. McGee Mucosal Immunology Second edition 1999 Academic Press San Diego 31 42
2. F.J. Cassels, and M.W. Wolf Colonization factors of diarrheagenic E. coli and their intestinal receptors FEMS Microbiol. Lett. 15 1995 214 226
3. O. Mol, and B. Oudega Molecular and structural aspects of fimbrial biosynthesis and assembly FEMS Microbiol. Lett. 19 1996 25 52
4. M.S. Donnenberg, J.B. Kaper, and B.B. Finlay Interactions between enteropathogenic Escherichia coli and host epithelial cells Trends Microbiol. 5 1997 109 114
5. C.J. Lee, and J. Mekalanos Bacterial interactions with intestinal epithelial cells P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.P. McGee Mucosal Immunology Second edition 1999 Academic Press San Diego 657 669
6. J.P. Nataro, and J.B. Kaper Diarrheagenic Escherichia coli Clin. Microbiol. Rev. 11 1998 142 201
7. R. Rappuoli, M. Pizza, G. Douce, and G. Dougan Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxin Immunol. Today 20 1999 493 500
8. A.D. O'Brien, and R.K. Holmes Shiga and shiga-like toxins Microbiol. Rev. 2 51 1987 206 220
9. J. Holmgren, and A. Rudin Mucosal immunity and bacteria P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.P. McGee Mucosal Immunology Second edition 1999 Academic Press San Diego 685 693
10. M. Kilian, J. Mestecky, and M.W. Russell Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases Microbiol. Rev. 52 1988 296 303
11. M.W. Russell, M. Kilian, and M.E. Lamm Biological activities of IgA P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.P. McGee Mucosal Immunology Second edition 1999 Academic Press San Diego 225 240
12. J. Mestecky, I. Moro, and B.J. Underdown Mucosal immunoglobulins P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.P. McGee Mucosal Immunology Second edition 1999 Academic Press San Diego 133 152
13. M. Kilian, and M.W. Russell Microbial evasion of IgA functions P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.P. McGee Mucosal Immunology Second edition 1999 Academic Press San Diego 241 251
14. F.B. Nikolova, M. Tomana, and M.W. Russell All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone Scand. J. Immunol. 39 1994 275 280
15. I.R. Sanderson, and W.A. Walker Mucosal barrier: an overview P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.P. McGee Mucosal Immunology Second edition 1999 Academic Press San Diego 5 17
16. L.S. Winner, J. Mack, R.A. Weltzin, J.J. Mekalanos, J.P. Kraehenbuhl, and M.R. Neutra New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection Infect. Immun. 59 1997 977 982
17. C.O. Elson, M.F. Kagnoff, C. Fiocchi, A.D. Befus, and S. Targan Intestinal immunity and inflammation: recent progress Gastroenterology 1986 746 768
18. J. Mestecky, and J.R. McGhee Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response Adv. Immunol. 40 1987 153 245
19. J.R. McGhee, M.E. Lamm, and W. Strober Mucosal immune responses: an overview P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.P. McGee Mucosal Immunology Second edition 1999 Academic Press San Diego 485 506
20. E.C. Butcher, and L.J. Picker Lymphocyte homing and homeostasis Science 272 1996 60 66
21. T. Kato, and R.L. Owens Structure and function of intestinal mucosal epithelium P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.P. McGee Mucosal Immunology Second edition 1999 Academic Press San Diego 31 42
22. P. Sicinski, J. Rowinski, J.B. Warchol, Z. Jarzcabek, W. Gut, B. Szczygiel, K. Bielecki, and G. Koch Poliovirus type 1 enters the human host through intestinal M cells Gastroenterology 98 1990 56 58
23. R.L. Owens Sequential uptake of horseradish peroxidase by lymphoid follicle epithelium of Peyer's patches in the normal unobstructed mouse intestine; an ultrastructural study Gastroenterology 72 1977 440 451
24. B.D. Jones, N. Ghori, and S. Falkow Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches J. Exp. Med. 180 1994 15 23
25. A. Gebert, H.J. Rothkotter, and R. Pabst M cells in Peyer's patches of the intestine Int. Rev. Cytol. 167 1996 91 159
26. J. Pappo, and T.H. Ermak Uptake and translocation of fluorescent latex particles by rabbit Peyer's patches follicle epithelium: a quantitative model for M cell uptak Clin. Exp. Immunol. 76 1989 144 148
27. D.T. O'Hagan The intestinal uptake of particles and the implications for drug and antigen delivery J. Anat. 189 Pt 3 1996 477 482
28. M.R. Neutra, A. Frey, and J.P. Kraehenbuhl Epithelial M cells: gateways for mucosal infection and immunization Cell 86 1996 345 348
29. A. Grutzkan, C. Hanski, H. Hahn, and E.O. Riecken Involvement of M cells in the bacterial invasion of Peyer's patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria Gut 31 1990 1011 1015
30. M.A. Marcial, and J.L. Madara Cryptosporidium: cellular localization, structural analysis of absorptive cell-parasite membrane interactions in guinea pigs, and suggestion of protozoan transport by m cell Gastroenterology 90 1986 583 594
31. A. Frey, K.T. Giannasca, R. Weltzin, P.J. Giannasca, H. Reggio, W.I. Lencer, and M.R. Neutra Role of the glycocalyx in regulating access of microparticles to apical membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting J. Exp. Med. 184 1996 1045 1059
32. D.T. O'Hagan Intestinal translocation of particulates-implications for drug and antigen delivery Adv. Drug Deliv. Rev. 5 1990 265 285
33. A.T. Florence The oral absorption of micro- and nanoparticulates: neither exceptional nor unusal Pharm. Res. 14 1997 259 266
34. G.F.A. Kersten, and B. Gander Biodegradable microspheres as vehicles for antigens S.H.E. Kaufman Concepts in Vaccine Development 1996 Walter de Gruyter Berlin 266 302
35. P.U. Jani, D.E. McCarthy, and A.T. Florence Nanosphere and microsphere uptake via Peyer's patches. Observation of the rate of uptake in the rat after a single dose Int. J. Pharm. 86 1992 239 246
36. J.H. Eldridge, J.K. Staas, J.A. Meulbroek, J.R. McGhee, T.R. Tice, and R.M. Gilley Biodegradable microspheres as a vaccine delivery system Mol. Immunol. 28 3 1991 287 294
37. T.H. Ermak, E.P. Dougherty, H.R. Bhagat, Z. Kabot, and J. Pappo Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer's patch M cells Cell Tissue Res. 279 1995 433 436
38. F. Zhou, J.P. Kraehenbuhl, and M.R. Neutra Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes Vaccine 13 1995 637 644
39. J. Nataro, and M.M. Levine Enteric bacterial vaccines: Salmonella, Shigella, Cholera, Escherichia coli P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.P. McGee Mucosal Immunology Second edition 1999 Academic Press San Diego 851 865
40. R.A. Cone Mucus P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.P. McGee Mucosal Immunology Second edition 1999 Academic Press San Diego 43 64
41. R.W. Ellis Technologies for making new vaccines S.A. Plotkin W.A. Orenstein Vaccine 2004 Saunders Philadelphia 1177 1197
42. M.M. Levine Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent J. Infect. Dis. 155 1987 377 389
43. D.T. O'Hagan Recent developments in vaccine delivery systems Curr. Drug Targets Infect. Dis. 1 2001 273 286
44. C. Moser, I.C. Metcalfe, and J.F. Viret Virosomal adjuvant antigen delivery systems Expert Rev. Vaccines 2 2003 189 196
45. G.F.K. Kersten, and D.J.A. Crommelin Liposomes and ISCOMs Vaccines 21 2003 915 920
46. E. Fattal, M.J. Blanco-Prieto, E. Leo, F. Puisieux, and P. Couvreur Design of nanoparticles for vaccine delivery B. Gander H.P. Merkle G. Corradin Antigen Delivery Systems: Immunological and Technological Issues 1997 Harwood Academic Amsterdam 139 157
47. D.T. O'Hagan, and M. Singh Microparticles as vaccine adjuvants and delivery systems Expert Rev. Vaccines 2 2003 269 283
48. J. Heller Controlled release from poly(orthoesters), a surface eroding polymer J. Control. Release 2 1985 167 177
49. K.W. Leong, J. Kost, E. Mathiowitz, and R. Langer Polyanhydrides for controlled release of bioactive agents Biomaterials 7 1986 364 371
50. B.S. Lakshmi, D.S. Katti, and C.T. Laurencin Biodegradable polyphosphazenes for drug delivery applications Adv. Drug Deliv. Rev. 55 2003 467 482
51. D.T. O'Hagan, M. Singh, and R.K. Gupta Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines Adv. Drug Deliv. Rev. 32 1998 225 246
52. W. Morris, M.C. Steinhoff, and P.K. Russell Potential of polymer microencapsulation technology for vaccine innovation Vaccine 12 1994 5 11
53. D.J. Jones Microencapsulation of vaccine antigens A. Robinson M.J. Hudson M.P. Cranage Vaccine Protocols 2003 Humana Press Totowa, NJ 211 222
54. R.I. Walker New strategies for using mucosal vaccination to achieve more effective immunization Vaccine 12 1994 387 400
55. R.M. Carr, C.M. Lolachi, R.G. Albaran, D.M. Ridley, P.C. Montgomery, and N.L. O'Sullivan Nasal-associated lymphoid tissue is an inductive site for rat tear IgA antibody responses Immunol. Invest. 25 1996 387 396
56. E.J. Frazza, and E.E. Schmitt A new absorbable suture J. Biomed. Mater. Res. Symp. 5 1971 43 48
57. D.T. O'Hagan, H. Jeffery, and S.S. Davis The preparation and characterization of poly(lactide-co-glycolide) microparticles: III. Microparticle/polymer degradation rates and the in vitro release of a model protein Int. J. Pharm. 103 1994 37 45
58. J.H. Eldridge, J.K. Staas, J.A. Meulbroek, T.R. Tice, and R.M. Gilley Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies Infect. Immun. 59 1991 2978 2986
59. D.T. O'Hagan, H. Jeffery, and S.S. Davis Long term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles Vaccine 11 1993 965 969
60. P. Giunchedi, and U. Conte Spray-drying as a preparation method of microparticulate drug delivery systems: an overview STP Pharma Sci. 5 1995 276 290
61. C. Thomasin, H. Nam-Tran, H.P. Merkle, and B. Gander Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics: 1. Overview and theoretical considerations J. Pharm. Sci. 87 1998 259 268
62. Y. Ogawa, M. Yamahoto, H. Okada, T. Yashiki, and T. Shimamot A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid Chem. Pharm. Bull. 36 1988 1095 1103
63. M.T. Aguado, and P.H. Lambert Controlled-release vaccine-biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles Immunobiology 184 1999 113 125
64. S. Watstein, and J. Jovanovic Bioterrorism and biological warfare Statistical Handbook on Infectious Diseases 2003 Greenwood Press Westport 292 298
65. J.A. Mobley Biological warfare in the twentieth century: lessons from the past, challenges for the future Mil. Med. 160 1995 547 553
66. S.A. Kolavic, A. Kimura, S.L. Simons, L. Slutsker, S. Barth, and C.E. Haley An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination JAMA 278 1997 396 398
67. C.N. Ramsay, and J. Marsh Giardiasis due to deliberate contamination of water supply Lancet 336 1990 880 881
68. J.A. Phills, A.J. Harrold, G.V. Whiteman, and L. Perelmutter Pulmonary infiltrates, asthma and eosinophilia due to Ascaris suum infestation in man N. Engl. J. Med. 286 1972 965 970
69. Deliberate spreading of typhoid in Japan Sci. Justice 2 1966 11 12
70. T.J. Torok, R.V. Tauxe, R.P. Wise, J.R. Livengood, R. Sokolow, S. Mauvais, K.A. Birkness, M.R. Skeels, J.M. Horans, and L.R. Foster A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars JAMA 278 1997 389 395
71. W.S. Carus The Rajneeshees (1984) J.B. Tucker Toxic Terror: Assessing Terrorist Use of Chemical and Biological Weapons 2001 MIT Press Cambridge 115 137
72. G.W. Christopher, T.J. Cieslak, J.A. Pavlin, and E.M. Eitzen Biological warfare: a historical perspective JAMA 278 1997 412 417
73. P. Gunby Enviroment adds to challenges facing Desert Shield physicians JAMA 265 1991 435 440
74. J.D. Simon Biological terrorism: preparing to meet the threat JAMA 278 1997 428 432
75. W.S. Cohen Foreword J. Lederberg Biological Weapons: Limiting the Threat 2001 MIT Press Cambridge xi xvi
76. K. Lowe, G.S. Pearson, and V. Utgoff Potential values of a simple biological warfare protective mask J. Lederberg Biological Weapons: Limiting the Threat 2001 MIT Press Cambridge 263 281
77. C. Yan, W.L. Rill, R. Malli, J. Hewetson, R. Tammariello, and M. Kende Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriers Vaccine 13 1995 645 651
78. C. Yan, W.L. Rill, R. Malli, J. Hewetson, H. Naseem, R. Tammariello, and M. Kende Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres Vaccine 14 1996 1031 1038
79. M. Kende, C. Yan, J. Hewetson, W.L. Frick, W.L. Rill, and R. Tammariello Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge Vaccine 20 2002 1681 1691
80. J.E. Eyles, I.D. Spiers, E.D. Williamson, and H.O. Alpar Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines Vaccine 16 1998 2000 2009
81. J.E. Eyles, E.D. Williamson, I.D. Spiers, and H.O. Alpar Protection studies following bronchopulmonary and intramuscular immunisation with Yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy Vaccine 18 2000 3266 3271
82. J.E. Eyles, G.J.E. Sharp, E.D. Williamson, I.D. Spiers, and H.O. Alpar Intranasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pheumonic plague in the mouse Vaccine 16 1998 698 707
83. G.J. Sharp, J.E. Eyles, E.D. Williamson, M.R. Brown, and H.O. Alpar Cellular and humoral responses to microencapsulated Yersinia pestis subunit vaccines following oral delivery Biochem. Soc. Trans. 25 1997 338S
84. L. Spero, A. Johnson-Winger, and J.J. Schmidt Enterotoxins of staphylococci C.M. Hardegree A.T. Tu Handbook of Natural Toxins 1988 Marcel Dekker New York 131 163
85. P.M. Schlievert Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 are significantly associated with non-menstrual TSS Lancet i 1986 1149 1150
86. J. Tseng, J.L. Komisar, J.Y. Chen, R.E. Hunt, A.J. Johnson, L. Pitt, and D.L. Ruble Immunity to aerosolized staphylococcal enterotoxin B Adv. Exp. Med. Biol. 371B 1995 1615 1619
87. J. Tseng, J.L. Komisar, R.N. Trout, R.E. Hunt, J.Y. Chen, A.J. Johnson, L. Pitt, and D.L. Ruble Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres Infect. Immun. 63 1995 2880 2885
88. P. Johansen, C. Raynaud, M. Yang, M.J. Colston, R.E. Tascon, and D.B. Lowrie Anti-mycobacterial immunity induced by a single injection of M. leprae Hsp65-encoding plasmid DNS in biodegradable microparticles Immun. Lett. 90 2003 81 85
89. K.M. Lima, S.A. Santos, V.M. Lima, A.A. Coelho-Castelo, J.M. Rodrigues Jr., and C.L. Silva Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis Gene Ther. 10 2003 678 685
90. N. Dhiman, and G.K. Khuller Protective efficacy of mycobacterial 71-kDa cell wall associated protein using poly(dl-lactide-co-glycolide) microparticles as carrier vehicles FEMS Immunol. Med. Microbiol. 21 1998 19 28
91. H.M. Vordermeier, A.G.A. Coombes, P.G. Jenkins, J.P. McGee, D.T. O'Hagan, S.S. Davis, and M. Singh Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles Vaccine 13 1995 1576 1582
92. M.A. Conway, L. Madrigal-Estebas, S. McClean, D.J. Brayden, and K.H. Mills Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells Vaccine 19 2001 1940 1950
93. R. Shahin, M. Leef, J. Eldridge, M. Hudson, and R. Gilley Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(dl-lactide-co-glycolide) microspheres Infect. Immun. 63 1995 1195 1200
94. E.S. Cahill, D.T. O'Hagan, L. Illum, A. Barnard, K.K.G. Mills, and K. Redhead Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles Vaccine 13 1995 455 462
95. D.H. Jones, B.W. McBride, and G.H. Farrar Poly(lactide-co-glycolide) microencapsulation of vaccine antigens J. Biotechnol. 44 1996 29 36
96. D.H. Jones, B.W. McBride, H. Jeffery, D.T. O'Hagan, A. Robinson, and G.H. Farrar Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae Vaccine 13 1995 675 681
97. M. Singh, A. Singh, and G.P. Talwar Controlled delivery of diphtheria toxoid using biodegradable poly(d,l-lactide) microcapsules Pharm. Res. 8 1991 958 961
98. P. Johansen, L. Moon, H. Tamber, H.P. Merkle, B. Gander, and D. Sesardic Immunogenicity of single-dose diptheria vaccines based on PLA/PLGA microspheres in guinea pigs Vaccine 18 2000 209 215
99. M. Peyre, D. Sesardic, H.P. Merkle, B. Gander, and P. Johansen An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria J. Pharm. Sci. 92 2003 957 966
100. M. Murillo, M.J. Grillo, J. Rene, C.M. Marin, M. Barberan, M.M. Goni, J.M. Blasco, J.M. Irache, and C. Gamazo Brucella ovis antigenic complex bearing poly-e-caprolactone microparticles confer protection against experimental brucellosis in mice Vaccine 19 2001 4099 4106
101. Z. Moldoveanu, M. Novak, W.Q. Huang, R.M. Gilley, J.K. Staas, D. Schafer, R.W. Compans, and J. Mestecky Oral immunization with influenza virus in biodegradable microspheres J. Infect. Dis. 167 1993 84 90
102. N. Santiago, S. Milsein, T. Rivera, E. Garcia, T. Zaidi, H. Hong, and D. Bucher Oral immunization of rats with proteinoid microspheres encapsulating influenza virus antigens Pharm. Res. 10 1993 1243 1247
103. R. Ray, M. Novak, J.D. Duncan, Y. Matsuoka, and R.W. Compans Microencapsulated human parainfluenza virus induces a protective immune response J. Infect. Dis. 167 1993 752 755
104. A.K. Hilbert, U. Fritzsche, and T. Kissel Biodegradable microspheres containing influenza A vaccine: immune response in mice Vaccine 17 1999 1065 1073
105. P.A. Marx, R.W. Compans, A. Gettie, J.K. Staas, R.M. Gilley, M.J. Mulligan, G.V. Yamshchikov, D. Chen, and J.H. Eldridge Protection against vaginal SIV transmission with microencapsulated vaccine Science 260 1993 1323 1327
106. J.D. Barackman, M. Singh, M. Ugozzoli, G.S. Ott, and D.T. O'Hagan Oral immunization with poly(lactide-co-glycolide) microparticles containing an entrapped recombinant glycoprotein (gD2) from Herpes simplex type 2 virus STP Pharma Sci. 8 1998 41 46
107. R.E. Black The epidemiology of cholera and enterotoxigenic E. coli diarrhea disease J. Holmgren A. Lindberg R. Möllby Development of Vaccines and Drugs Against Diarrhea 11th Nobel Conference, Stockholm, 1986 1986 Studentlitteratur Lund 22 32
108. E.C. Todd Epidemiology of foodborne diseases: a worldwide review World Health Stat. Q. 50 1997 30 50
109. K.C. Hyams, A.L. Bourgeois, B.R. Merrell, P. Rozmajzl, J. Escamilla, S.A. Thornton, G.M. Wasserman, A. Burke, P. Echeverria, and K.Y. Green Diarrheal disease during Operation Desert Shield N. Engl. J. Med. 325 1991 1423 1428
110. P. Ogra, M. Lamm, J. Bienenstock, W. Strober, and J. McGhee Mucosal immunology P.L. Ogra J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.P. McGee Mucosal Immunology Second edition 1999 Academic Press San Diego
111. S. Guandalini Acute diarrhea W.A. Walker P.R. Durie J.R. Hamilton J.A. Walker-Smith J.B. Watkins Pediatric Gastrointestinal Disease 2000 B.C. Decker Hamilton, Ontario 28 38
112. M.K. Wolf Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli Clin. Microbiol. Rev. 10 1997 569 584
113. A. Rudin, and A.-M. Svennerholm Colonization factor antigens (CFAs) of enterotoxigenic Escherichia coli can prime and boost immune responses against heterologous CFAs Microb. Pathog. 16 1994 131 139
114. D.J. Freedman, C.O. Tacket, A. Delehanty, D.R. Maneval, J. Nataro, and J.H. Crabb Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli J. Infect. Dis. 177 1998 662 667
115. A. Helander, C. Wenneras, F. Qadri, and A. Svennerholm Antibody responses in humans against coli surface antigen 6 of enterotoxigenic Escherichia coli Infect. Immun. 66 1998 4507 4510
116. D.J. Evans Jr., D.G. Evans, A.R. Opekun, and D.Y. Graham Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2 FEMS Microbiol. Immunol. 1 1988 9 18
117. D.G. Evans, D.J.J. Evans, A. Opekun, and D.Y. Graham Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes FEMS Microbiol. Immunol. 47 1988 117 126
118. M. Jertborn, C. Ahren, J. Holmgren, and A.M. Svennerholm Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine Vaccine 16 1998 255 260
119. S.J. Savarino, F.M. Brown, E. Hall, S. Bassily, F. Youssef, T. Wierzba, L. Peruski, N.A. El-Masry, M. Safwat, M. Rao, M. Jertborn, A.M. Svennerholm, Y.J. Lee, and J.D. Clemens Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults J. Infect. Dis. 177 1998 796 799
120. S.J. Savarino, E. Hall, S. Bassily, T.F. Wierzba, F.G. Yousef, and L.F. Peruski Introductory evaluation of an oral, killed whole cell enterotoxigenic Eshcerichia coli plus cholera toxin B subuint vaccine in Egyptian infants Pediatr. Infect. Dis. J. 21 2002 322 330
121. A.K. Turner, T.D. Terry, D.A. Sack, P. Londono-Arcila, and M.J. Darsley Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans Infect. Immun. 69 2001 4969 4979
122. E.M. Barry, Z. Altboum, G. Losonsky, and M.M. Levine Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains Vaccine 21 2003 333 340
123. D.G. Evans, D.Y. Graham, and D.J. Evans Jr. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli Gastroenterology 87 1984 934 940
124. G. Glenn, R.T. Kenney, L.R. Ellingsworth, S.A. Frech, S.A. Hammond, and J.P. Zoeteweij Transcutaneous immunization and immunostimulant strategies: capitalizating on the immunocompetence of the skin Expert Rev. Vaccines 2 2003 253 267
125. J. Yu, F. Cassels, T. Scharton-Kersten, S.A. Hammond, A. Hartman, E. Angov, B. Corthesy, C. Alving, and G. Glenn Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli Infect. Immun. 70 2002 1056 1068
126. F. Guerena-Burgueno, E.R. Hall, D.N. Taylor, F.J. Cassels, D.A. Scott, M.K. Wolf, Z.J. Roberts, G.V. Nesterova, C.R. Alving, and G.M. Glenn Safety and immunogenicity of a prototype enterotoxigenic Escherichia col vaccine administered transcutaneously Infect. Immun. 70 4 2002 (Apr) 1874 1880 ((2002) Infect. Immun. 70 (2002) 1874-1880)
127. C.E. McQueen, E.C. Boedeker, R. Reid, D. Jarboe, M. Wolf, M. Le, and W.R. Brown Pili in microspheres protect rabbits from diarrhoea induced by E. coli strain RDEC-1 Vaccine 11 1993 201 206
128. R.H. Reid, E.C. Boedeker, C.E. McQueen, D. Davis, L.Y. Tseng, J. Kodak, K. Sau, C.L. Wilhelmsen, R. Nellore, P. Dalal, and H.R. Bhagat Preclinical evaluation of microencapsulated CFA/II oral vaccine against enterotoxigenic E. coli Vaccine 11 1993 159 167
129. A.J. de Lorimier, W. Byrd, E.R. Hall, W.M. Vaughan, D. Tang, Z.J. Roberts, C.E. McQueen, and F.J. Cassels Murine antibody response to intranasally administered enterotoxigenic Escherichia coli colonization factor CS6 Vaccine 21 2003 2548 2555
130. D.E. Katz, A.J. DeLorimier, M.K. Wolf, E.R. Hall, F.J. Cassels, J.E. van Hamont, R.L. Newcomer, M.A. Davachi, D.N. Taylor, and C.E. McQueen Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen Vaccine 21 2003 341 346
131. CDC Recommended childhood and adolescent immunization schedule-United States MMWR 53 2004 1 4
132. E. Mast, F. Mahoney, M. Kane, and H. Margolis Hepatitis B vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 299 337
133. M. Wharton, and C.R. Vitek Diphtheria toxoid S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 211 228
134. S.G.F. Wassilak, M.H. Roper, T.V. Murphy, and W.A. Orenstein Tetanus toxoid S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 745 781
135. K.M. Edwards, and M.D. Decker Pertussis vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 471 528
136. J.D. Wenger, and J.I. Ward Haemophilus influenzae vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 229 268
137. S.A. Plotkin, and E. Vidor Poliovirus vaccine-inactivated S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 625 649
138. P.M. Strebel, M.J. Papania, and N.A. Halsey Measles vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 389 440
139. S.A. Plotkin Mumps vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 441 469
140. S.A. Plotkin, and S. Reef Rubella vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 707 743
141. A.A. Gershon, M. Takahashi, and J. Seward Varicella vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 783 823
142. J. Eskola, S. Black, and H. Shinefield Pneumococcal conjugate vaccines S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia
143. D.S. Fedson, and D.M. Musher Pneumococcal polysaccharide vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 529 588
144. B.P. Bell, and S.M. Feinstone Hepatitis A vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 269 297
145. K. Fukuda, R.A. Levandowski, C.B. Bridges, and N.J. Cox Inactivated influenza vaccines S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 339 370
146. R.B. Belshe, H.F. Maassab, and P.M. Mendelman Influenza vaccine-live S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 371 388
147. CDC General recommendations on immunization. Recommendations of the advisory committee on immunization practices (ACIP) MMWR 42 RR 1994 1 38
148. C.A. Gaydos, and J.C. Gaydos Adenovirus vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 863 885
149. K.C. Smith, and J.R. Starke Bacille Calmette-Guerin vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 179 209
150. R.W. Suter, O.M. Kew, and S.L. Cochi Poliovirus vaccine-live S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 651 705
151. D.A. Sack, and D.R. Lang Cholera vaccines S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 905 917
152. S.B. Halstead, and T.F. Tsai Japanese encephalitis vaccines S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 919 958
153. D.M. Granoff, I.M. Feavers, and R. Borrow Meningococcal vaccines S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 959 987
154. S.A. Plotkin, C.E. Rupprecht, and H. Koprowski II Rabies vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 1011 1038
155. M.M. Levine Typhoid fever vaccines S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 1057 1093
156. T.P. Monath Yellow fever vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 1095 1176
157. P.S. Brachman, A.M. Friedlander, and J.D. Grabenstein Anthrax vaccine S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 887 903
158. D.A. Henderson, L.L. Borio, and J.M. Lane Smallpox and vaccinia S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 123 153
159. R.W. Titball, E.D. Williamson, and D.T. Dennis Plague S.A. Plotkin W.A. Orenstein Vaccines Fourth edition 2004 Saunders Philadelphia 999 1010